# Phillips Pharmaceuticals (Nigeria) — NAFDAC-Registered Products & Company Profile

Phillips Pharmaceuticals (Nigeria) holds 73 active NAFDAC product registrations in our October 2026 copy of the Greenbook.

- Source: https://ogbogwu.com/manufacturers/phillips-pharmaceuticals-nigeria/
- NAFDAC-registered products: 73 · Antibiotics, Diabetes, Pain & Fever
- Made in: India (56), France (3), Germany (3)
- Website: phillipspharmaceuticals.com (https://phillipspharmaceuticals.com)
- Address & phone: Not on record here — see the official website.
- Rank by registered products: 3 of 533 manufacturers tracked (October 2026 copy)
- Nigerian company: yes

## Register profile (October 2026 copy)

Phillips Pharmaceuticals (Nigeria) has 73 products registered with NAFDAC for the Nigerian market in our October 2026 copy of the Greenbook, placing it #3 by registered products among the 533 companies in Ogbogwu's registry index. The full list below is compiled from that copy of the NAFDAC Greenbook — Nigeria's official register of approved products.
Its registrations span drugs (60), vaccines and biologics (12) and herbals and nutraceuticals (1). Its medicines are strongest in Antibiotics (11 products), Diabetes (6 products) and Pain & Fever (5 products). Its vaccines and biologics range covers insulin regular (4), isophane insulin (2) and recombinant human epidermal growth factor (2). Registered brands include Auroxetil 250 mg, Benylin 4 Flu Syrup and Brozelin Syrup. Most of its products are registered as tablet, capsule and solution for injection formulations. 34 of its products link through to full Ogbogwu drug guides covering uses, dosage, prices, and NAFDAC verification. Phillips Pharmaceuticals (Nigeria) is the registration holder rather than the physical maker: the Greenbook records factories abroad for its products (mostly India).

## Product categories (October 2026 copy)

- Antibiotics: 11 products
- Diabetes: 6 products
- Pain & Fever: 5 products

## Registered products in our October 2026 copy (first 60 of 73)

| Product | NAFDAC Reg. No. | Strength | Form |
|---|---|---|---|
| Auroxetil 250 mg | A4-4002 | 250 mg | Tablet |
| Auroxetil 500 mg Tablet | A4-4190 | 500 mg | Tablet |
| Benylin 4 Flu Syrup | B4-9043 | 1000 mg/20 mL; 45 mg/20 mL; 25 mg/20 mL | Syrup |
| Betadine Germicide Gargle | 04-4013 | 2% | Gargle |
| Betadine Standardized Microbicidal Solution 10% w/v | A1-4924L | 10% | Solution |
| Betadine Surgical Scrub | 04-4018 | 7.5% | Solution |
| Brozelin Syrup | A4-3215 | 2 mg/5 mL; 30 mg/5 mL; 50 mg/5 mL; 1 mg/5 mL | Syrup |
| Cefakind 250 Tablets | B4-1806 | 250 mg | Tablet |
| Cefakind 500 Tablets | B4-1239 | 500 mg | Tablet |
| Ceftatime-1000 Powder for Injection | B4-3307 | 1 g | Powder for injection |
| Ceftatime-SB 1.5 Powder for Injection | B4-4230 | 1000 mg; 500 mg | Powder for injection |
| Colecalciferol Injection | C4-2031 | 6000 IU/mL | Injection |
| Corbis 10 Tablet | A4-4671 | 10 mg | Tablet |
| Corbis-5 Tablets | A4-4672 | 5 mg | Tablet |
| Descovy 200 mg/10 mg Tablet | B4-9408 | 200 mg; 10 mg | Tablet |
| Descovy 200 mg/25 mg Tablets | C4-0002 | 200 mg; 25 mg | Tablet |
| Dexmedetomidine Hydrochloride Injection 100 mcg/mL | A4-100658 | 100 mcg/mL | Solution for injection |
| Diclofenac Gel | C4-1961 | 1% | Gel |
| Dilcontin XL 90 Tablet | A4-5844 | 90 mg | Tablet |
| Drez V | A4-100883 | 1%; 2% | Gel |
| Fluimucil 600 mg Effervescent Tablets | B4-2557 | 600 mg | Effervescent tablet |
| Hidrasec Capsule 100 mg | B4-7104 | 100 mg | Capsule |
| Hidrasec Granules for Oral Suspension (Children) | B4-7102 | 30 mg | Granules for suspension |
| Hidrasec Granules for Oral Suspension (Infant) 10 mg | B4-7103 | 10 mg | Granules for suspension |
| Hytan 80 Tablet Telmisartan 80 mg | A4-100770 | 80 mg | Tablet |
| Hytan Tablet | A4-100769 | 40 mg | Tablet |
| Lopinavir 200 mg/Ritonavir 50 mg | A4-3852 | 200 mg; 50 mg | Tablet |
| Lumartem 20/120 mg | A4-4845 | 20 mg; 120 mg | Tablet |
| Lumartem Dispersible Tablets (DT) | B4-7310 | 20 mg; 120 mg | Dispersible tablet |
| Menaven Gel | B4-7696 | 1000 IU/g | Gel |
| Monuril Granules | B4-4173 | 3 g | Granules for solution |
| Moxikind-CV 228.5 Powder for Oral Suspension | B4-1128 | 200 mg | Powder for suspension |
| Moxikind-Cv 375 Tablets | B4-1672 | 250 mg; 125 mg | Tablet |
| Moxikind-Cv 625 Tablets | B4-1129 | 500 mg; 125 mg | Tablet |
| Mylovasc 2.5 Tablet | A4-9649 | 2.5 mg | Tablet |
| Mylovasc 5 mg | A4-9650 | 5 mg | Tablet |
| Myospaz Tablet | B4-3633 | 250 mg; 500 mg | Tablet |
| Nevimune Oral Suspension | A4-100152 | 50 mg/5 mL | Suspension |
| Nevirapine | 04-8377 | 50 mg/5 mL | Suspension |
| Nevirapine Tablets 200 mg Tablet | 04-7679 | 200 mg | Tablet |
| Nitrocontin 2.6 | A4-7838 | 2,6mg | Tablet |
| Nitrocontin 6.4 | A4-7839 | 6.4mg | Tablet |
| Palonosetron Hydrochloride Injection 0.075 mg/1.5 mL | A4-100667 | 0.075 mg/1.5 mL | Solution for injection |
| Pregasafe 150 Pregabalin Capsules | A4-9042 | 150 mg | Capsule |
| Pregasafe 75 Pregabalin Capsules | A4-9007 | 75 mg | Capsule |
| Q-Tib Tablets | B4-9116 | 300 mg; 25 mg; 800 mg; 160 mg | Tablet |
| Rancv 500 | B4-8445 | 500 mg | Tablet |
| Regen-D 150 | A6-0033 | 150 mcg/g | Gel |
| Regen-D 60 | A6-0032 | 60 mcg/g | Dermal gel |
| Revac-B 1 mL Single Dose | A6-0147 | 20 mcg/mL | Suspension for injection |
| Revac-B 10 mL Multi-dose | A6-0456 | 200 mcg/10 mL | Suspension for injection |
| Silotrif 4 mg Capsule | B4-9490 | 4 mg | Capsule |
| Silotrif 8 mg Capsule | B4-8366 | 8 mg | Capsule |
| Stednac Gel | A4-100649 | 1.5%; 10%; 5%; 3% | Gel |
| Sulbacin 0.75 Injection | A4-2388 | 750 mg | Powder for injection |
| Tagera Forte Tablet | A4-4663 | 1 g | Tablet |
| Tamcontin 0.4 mg Tablet | A4-101181 | 0.4 mg | Tablet |
| Truvada Tablets | 04-8774 | 200 mg; 300 mg | Tablet |
| Typbar Vi Capsular Polysaccharide Typhoid Vaccine | A6-0446 | 125 mcg/2.5 mL | Solution for injection |
| Typbar Vi Capsular Polysaccharide Vaccine 0.5 | A6-0146 | 25 mcg/ 0.5mL | Solution for injection |

Verify any NAFDAC number free: https://ogbogwu.com/nafdac-checker/